| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/22/2009 | WO2009010455A2 Pyrazole derivatives as modulators of metabotropic glutamate receptors |
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090022757 Method for treating photoreceptor cell degeneration |
| 01/22/2009 | US20090022728 Methods of treating ophthalmic diseases |
| 01/22/2009 | US20090022703 Treating age-related macular degeneration associated with a loss of elastic fibers by administering a LOXL1 polypeptide that can catalyze the crosslinking of elastin |
| 01/22/2009 | CA2696016A1 Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016945A1 Pharmaceutical containing thiazole derivative as active ingredient |
| 01/21/2009 | EP2016944A2 Angiogenesis inhibitor containing a derivative of rifampicin |
| 01/21/2009 | EP2015767A2 New approach to treat intraocular hypertension |
| 01/21/2009 | EP2015644A1 Animal food composition comprising genistein and polyunsaturated fatty acids |
| 01/21/2009 | EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/21/2009 | EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof |
| 01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
| 01/21/2009 | CN101351230A Implantable biocompatible immunoisolatory vehicle for delivery of GDNF |
| 01/21/2009 | CN101348798A Construction of recombinant adenovirus vector expressing bFGF protein and use of recombinant adenovirus vector for in vivo ear transfection |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347620A Medicament composition and use thereof in preparing medicament for treating glaucoma |
| 01/21/2009 | CN101347619A Medicament composition and use thereof in preparing medicament for treating inflammation of eye section |
| 01/21/2009 | CN101347481A Wild chrysanthemum in situ forming eye gel |
| 01/21/2009 | CN101347450A Chondroitin sulfate in situ forming eye gel |
| 01/21/2009 | CN101347448A Dextran in situ forming eye gel |
| 01/21/2009 | CN101347447A Hypromellose in situ forming eye gel |
| 01/21/2009 | CN101347444A Compound naphazoline hydrochloride in situ forming eye gel |
| 01/21/2009 | CN101347443A Vitamin B12 in situ forming eye gel |
| 01/21/2009 | CN101347438A Medicament for slowing down angiogenesis of eye section |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453086C Gel for removing ocular by ice pearl and its preparation |
| 01/21/2009 | CN100453074C Sustained release drug delivery device |
| 01/21/2009 | CN100453066C Drug delivery system using subconjunctival depot |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2423252C Photosensitisers |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/15/2009 | WO2009008511A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 01/15/2009 | WO2009007839A1 Pharmaceutical compositions and methods of treating dry eye disorders |
| 01/15/2009 | WO2009007814A1 Inhibitors of carbonic anhydrase |
| 01/15/2009 | WO2009007746A2 Treatment of sensorineural hearing loss |
| 01/15/2009 | WO2009007457A2 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | WO2009007348A2 Use of antagonists of g protein coupled receptors (gpcrs) for treating diseases caused by agonistic autoantibodies activated gpcrs |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2008110885A3 Methods of treating ophthalmic diseases |
| 01/15/2009 | US20090018181 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/15/2009 | US20090018168 administering 5-(3-((1R,2R,3R,5R)-5-chloro-2-((3,5-dichlorophenylthio)methyl)-3-hydroxycyclopentyl)propyl)-thiophene-2-carboxylic acid to reduce intraocular pressure; treating glaucoma |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018129 compounds that interfere with tyrosine kinase signalling such as 1-{3-Amino-1-methyl-4-[4-(3-phenyl-ureido)-phenyl]-1H-pyrazolo[3,4-b]pyridin-6-yl}-cyclopropanecarboxylic acid ethyl ester, used for the treatment of diseases of dysregulated vascular growth such as retinopathy |
| 01/15/2009 | US20090018119 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 01/15/2009 | US20090018100 Materials and methods for treating ocular-related disorders |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018057 OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
| 01/15/2009 | US20090017098 Composition and method for the prevention and relief of the symptoms of an incompetent or patulous eustachian tube |
| 01/15/2009 | US20090017097 Hydrogel polymeric compositions and methods |
| 01/15/2009 | US20090017043 Connective tissues growth factor antibodies |
| 01/15/2009 | US20090017029 Methods and Compositions for Treating Ocular Disorders |
| 01/15/2009 | US20090017002 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
| 01/15/2009 | CA2693646A1 Normal-tension glaucoma model and method for evaluation of test substances by using same |
| 01/15/2009 | CA2692485A1 Compounds and methods for modulating rho gtpases |
| 01/14/2009 | EP2014679A1 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014678A2 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014651A1 Compounds and methods for modulating Rho GTPases |
| 01/14/2009 | EP2014333A1 Use of cooling agents for treatment or prevention of lacrimation or eye burning |
| 01/14/2009 | EP2014297A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 01/14/2009 | EP2012826A2 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases |
| 01/14/2009 | EP2012789A1 Method of treatment of age-related macular degeneration(amd) |
| 01/14/2009 | EP2012767A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye |
| 01/14/2009 | EP1549741B1 Novel endothelial cells, antibodies against said cells and use thereof |
| 01/14/2009 | EP1516620B1 Rifampicin for treating angiogenesis |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP1187918B2 Tek antagonists |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP0841937B2 Use of betaglycan to reduce scarring |
| 01/14/2009 | CN101346145A Use of anecortave acetate as an adjunct during filtration bleb surgery |
| 01/14/2009 | CN101346138A Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 01/14/2009 | CN101346136A Protection of oxidizable agents |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101342370A Instant jelly glue of carbomer for eyes |
| 01/14/2009 | CN101342291A Chinese medicinal composition for preventing and controlling hypometropia, and preparation method |
| 01/14/2009 | CN101342265A Instant jelly glue of musk deer bead for eyes |
| 01/14/2009 | CN101342250A Bolus for clearing away heat of the upper part of the body |
| 01/14/2009 | CN101342242A Instant jelly glue of double coptis for eyes |
| 01/14/2009 | CN101342182A Instant gel rubber of physostigmine salicylate for eyes |
| 01/14/2009 | CN101342180A Medicament composition for eyes and preparation method thereof |
| 01/14/2009 | CN101342178A Instant gel rubber of latanoprost for eyes |
| 01/14/2009 | CN101342176A Instant gel rubber of timolol maleate for eyes |
| 01/14/2009 | CN101342172A Instant gel rubber of pilocarpine nitrate for eyes |